Over the years, there have been many efforts to identify in-vitro diagnostics, in cerebral spinal fluid (CSF) or blood, for Alzheimer’s disease (AD). While there have been many studies, nothing has become used in routing clinical practice. Is this a function of the biomarker discovery process, or is it the result of other reasons? A… Read More Alzheimer’s Disease Biomarkers – Are In-vitro Diagnostics Really Needed?